The acceptance of the auto-immune theory has dominoed into the type of treatments available for MS. Because cytokines are the cause of much of the damage upon the glial cells during the immune attack, researchers have sought out ways to suppress the inflammatory response. One newly FDA approved drug therapy used to treat MS is thalidomide, which has anti-inflammatory and immunosuppressant effects making it ideal for these conditions (7). Marketed in the past as a mild sedative, it was pulled off the drugstore shelves when it was proven to cause dangerous birth defects in pregnant women (7). Another drug therapy utilized to treat MS is methprednisolone, a synthetic adrenal steroid hormone, which has powerful effects on suppressing inflammation. Shortening any flare-ups of MS, the drug does not permanently retard progression of the disorder (4). Newer drugs hold greater promise of beneficial effects. Many of them are beta-interferons, which reduce the frequency of flares by about 30% by reducing the number of cytokines in the brain (4). The three forms of treatment stated above seem to be the most recent and well-prescribed by physicians who treat victims of MS. Upon searching the Internet further, it was found that there were hardly any treatments for patients with MS that were not pharmacological. One homeopathic treatment of MS dealt with strengthening the blood-brain barrier (BBB), such that no immune cells could pass through. Not approved by the FDA, it was a suggestion found on a personal home page of a man concerned with treatments for MS. He believed that the increase of flavonoids in a person’s diet would strengthen the BBB to the extent that no further breakdowns would occur (8). The nonpharmacological treatments did not seem as commonly recommended as the pharmacological. This may return to a fear of the scientific community of the unknown, of things that cannot be